Ranitidine
- Product NDC
- 63629-7669
- 11-digit product format
- 636297669
- Labeler code
- 63629
- Product ID
- 63629-7669_32436bef-1898-4eb1-8a9b-ec560c24d855
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA077824
- Marketing category
- ANDA
- Marketing start
- 2009-12-16
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 150 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 63629-7669-1 | 63629766901 | 20 TABLET in 1 BOTTLE (63629-7669-1) | 20 tablet | 2018-05-30 | 0000-00-00 | No | No | Current |
| 63629-7669-2 | 63629766902 | 30 TABLET in 1 BOTTLE (63629-7669-2) | 30 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |
| 63629-7669-3 | 63629766903 | 60 TABLET in 1 BOTTLE (63629-7669-3) | 60 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |
| 63629-7669-4 | 63629766904 | 90 TABLET in 1 BOTTLE (63629-7669-4) | 90 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |
| 63629-7669-5 | 63629766905 | 300 TABLET in 1 BOTTLE (63629-7669-5) | 300 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |
| 63629-7669-6 | 63629766906 | 500 TABLET in 1 BOTTLE (63629-7669-6) | 500 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |
| 63629-7669-7 | 63629766907 | 800 TABLET in 1 BOTTLE (63629-7669-7) | 800 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |
| 63629-7669-8 | 63629766908 | 1000 TABLET in 1 BOTTLE (63629-7669-8) | 1000 tablet | 2021-12-23 | 0000-00-00 | No | No | Current |